Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)
Hong Kong · Delayed Price · Currency is HKD 18.97
+0.07 (0.37%)
At close: Dec 5, 2025
HKG:0874 Market Cap
HKG:0874 has a market cap or net worth of 44.33 billion as of December 5, 2025. Its market cap has decreased by -8.91% in one year.
Market Cap
44.33B
Enterprise Value
44.16B
Revenue
84.74B
Ranking
n/a
PE Ratio
13.58
Stock Price
18.97
Market Cap Chart
Since February 6, 2001, HKG:0874's market cap has increased from 3.51B to 44.33B, an increase of 1,161.73%. That is a compound annual growth rate of 10.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 44.33B | -4.72% |
| Dec 31, 2024 | 46.52B | -5.21% |
| Dec 29, 2023 | 49.08B | -6.35% |
| Dec 30, 2022 | 52.40B | -18.06% |
| Dec 31, 2021 | 63.96B | 20.63% |
| Dec 31, 2020 | 53.02B | -14.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 285.39B |
| Hansoh Pharmaceutical Group Company | 253.90B |
| JD Health International | 192.57B |
| Innovent Biologics | 160.32B |
| WuXi Biologics | 135.64B |
| Sino Biopharmaceutical | 122.99B |
| Akeso | 113.67B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.70B |